Mechanism for biphasic rel A. NF-kappaB1 nuclear translocation in tumor necrosis factor alpha-stimulated hepatocytes

J Biol Chem. 1997 Apr 11;272(15):9825-32. doi: 10.1074/jbc.272.15.9825.

Abstract

The proinflammatory cytokine, tumor necrosis factor alpha (TNFalpha), is a potent activator of angiotensinogen gene transcription in hepatocytes by activation of latent nuclear factor-kappaB (NF-kappaB) DNA binding activity. In this study, we examine the kinetics of TNFalpha-activated translocation of the 65-kDa (Rel A) and 50-kDa (NF-kappaB1) NF-kappaB subunits mediated by inhibitor (IkappaB) proteolysis in HepG2 hepatoblastoma cells. HepG2 cells express the IkappaB members IkappaBalpha, IkappaBbeta, and IkappaBgamma. In response to TNFalpha, Rel A.NF-kappaB1 translocation and DNA binding activity follows a biphasic profile, with an "early" induction (15-30 min), followed by a nadir to control levels at 60 min, and a "late" induction (>120 min). The early phase of Rel A.NF-kappaB1 translocation depends on simultaneous proteolysis of both IkappaBalpha and IkappaBbeta isoforms; IkappaBgamma is inert to TNFalpha treatment. The 60-min nadir is due to a rapid IkappaBalpha resynthesis that reassociates with Rel A and completely inhibits its DNA binding activity; the 60-min nadir is not observed when IkappaBalpha resynthesis is prevented by cycloheximide treatment. By contrast, selective inhibition of IkappaBbeta proteolysis by pretreatment of HepG2 cells with the peptide aldehyde N-acetyl-Leu-Leu-norleucinal completely blocks the late phase of Rel A.NF-kappaB1 translocation. These studies indicate the presence of inducible and constitutive cytoplasmic NF-kappaB pools in hepatocytes. TNFalpha induces a coordinated proteolysis and resynthesis of IkappaB isoforms to produce dynamic changes in NF-kappaB nuclear abundance.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Nucleus / metabolism
  • Cysteine Proteinase Inhibitors / pharmacology
  • DNA / metabolism
  • DNA-Binding Proteins / metabolism
  • Humans
  • I-kappa B Proteins*
  • Leupeptins / pharmacology
  • Liver / drug effects*
  • Liver / metabolism
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism*
  • NF-kappa B p50 Subunit
  • Protein Precursors / metabolism
  • Proto-Oncogene Proteins / metabolism
  • Proto-Oncogene Proteins c-rel
  • Recombinant Proteins / metabolism
  • Transcription Factor RelA
  • Transcription Factor RelB
  • Transcription Factors*
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Cysteine Proteinase Inhibitors
  • DNA-Binding Proteins
  • I kappa B beta protein
  • I-kappa B Proteins
  • Leupeptins
  • NF-kappa B
  • NF-kappa B p50 Subunit
  • NFKBIA protein, human
  • Protein Precursors
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-rel
  • RELB protein, human
  • Recombinant Proteins
  • Transcription Factor RelA
  • Transcription Factors
  • Tumor Necrosis Factor-alpha
  • acetylleucyl-leucyl-norleucinal
  • NF-KappaB Inhibitor alpha
  • Transcription Factor RelB
  • DNA